Long-term results of teduglutide treatment for chronic intestinal failure – Insights from a national, multi-centric patient home-care service program
ORIGINAL ARTICLE| VOLUME 51, P222-230, OCTOBER 2022 Sophie Greif, Sebastian Maasberg, Jan Wehkamp, Elisabeth Blüthner, Frank Tacke, Ulrich-Frank PapeDOI: https://doi.org/10.1016/j.clnesp.2022.08.027 Abstract Background & aims: Teduglutide is a Glucagon-like peptide-2 (GLP-2) agonist indicated for the treatment of patients with parenteral support (PS) dependent short bowel syndrome (SBS) with chronic intestinal failure (cIF). Its application is accompanied by a structured […]